Cite
De la Garza-Ramos C, Overfield CJ, Montazeri SA, et al. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. J Hepatocell Carcinoma. 2021;8:861-870doi: 10.2147/JHC.S319215.
De la Garza-Ramos, C., Overfield, C. J., Montazeri, S. A., Liou, H., Paz-Fumagalli, R., Frey, G. T., McKinney, J. M., Ritchie, C. A., Devcic, Z., Lewis, A. R., Harnois, D. M., Patel, T., & Toskich, B. B. (2021). Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. Journal of hepatocellular carcinoma, 8861-870. https://doi.org/10.2147/JHC.S319215
De la Garza-Ramos, Cynthia, et al. "Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated." Journal of hepatocellular carcinoma vol. 8 (2021): 861-870. doi: https://doi.org/10.2147/JHC.S319215
De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. J Hepatocell Carcinoma. 2021 Jul 30;8:861-870. doi: 10.2147/JHC.S319215. eCollection 2021. PMID: 34368021; PMCID: PMC8335548.
Copy
Download .nbib